Market Overview
The Nucleic Acid Therapeutics Market was valued at US$ 5.64 billion in 2024 and is projected to reach US$ 14.42 billion by 2032, registering a CAGR of 10.9% throughout the forecast period 2025–2032. The Nucleic Acid Therapeutics Market explodes with gene-targeting innovations like ASOs and mRNA, tackling cancers and genetic disorders via RNA interference. R&D surges...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)